Imaging During Pregnancy: What Is Safe

Diagnostic imaging during pregnancy requires careful matching of clinical urgency against fetal radiation exposure, acoustic energy, and contrast agent risks. This page covers the four primary imaging modalities used in obstetric and non-obstetric contexts — X-ray, CT, MRI, and ultrasound — their known risk profiles, and the decision frameworks that guide clinician and radiologist choices. Understanding these distinctions matters because undertreated maternal illness carries its own fetal risks, making blanket avoidance of imaging as dangerous as indiscriminate use.

Definition and Scope

Imaging safety during pregnancy is governed by the principle that no imaging study should be withheld when the clinical indication is strong, yet no study should be performed when a lower-risk alternative yields equivalent diagnostic information. The American College of Radiology (ACR) and the American College of Obstetricians and Gynecologists (ACOG) both publish formal guidance on this principle, with ACOG's Committee Opinion No. 723 specifically addressing guidelines for diagnostic imaging during pregnancy and lactation.

The scope of concern encompasses:

Radiation dose to the fetus is measured in milligrays (mGy). The ACR and ACOG both cite a threshold of 50 mGy as the level below which deterministic fetal effects (growth restriction, organ malformation) are not expected. The overwhelming majority of diagnostic studies remain well below this threshold. The broader regulatory and professional framework governing radiology practice is detailed in the regulatory context for radiology.

How It Works

Each modality interacts with fetal tissue through a distinct physical mechanism, which determines its risk category.

Ionizing Radiation Modalities

X-ray and fluoroscopy deliver doses measured in fractions of a milligray for most projections. A standard chest X-ray delivers approximately 0.0005–0.01 mGy to the fetus — far below any threshold of clinical concern, according to published data in the ACR Manual on Contrast Media and related ACOG documentation. Abdominal and pelvic X-rays deliver higher doses, typically 1–3 mGy, still below the 50 mGy concern threshold.

CT scanning varies substantially by anatomical region. A CT of the chest delivers an estimated 0.01–0.66 mGy of fetal dose; a CT of the abdomen and pelvis can deliver 10–50 mGy, approaching but generally remaining within the threshold range. Iterative reconstruction techniques and dose-reduction protocols lower these figures further, as discussed in radiation safety in CT.

Nuclear medicine studies using technetium-99m typically deliver 1–5 mGy to the fetus, while studies using radioactive iodine (I-131) carry a specific contraindication after 10–12 weeks of gestation, when the fetal thyroid begins concentrating iodine (NRC 10 CFR Part 35).

Non-Ionizing Modalities

MRI uses magnetic fields and radiofrequency energy rather than ionizing radiation, making it the preferred cross-sectional modality when CT-level detail is required and radiation reduction is prioritized. The main fetal concern during the first trimester is theoretical tissue heating from radiofrequency energy, though no confirmed fetal harm from clinical MRI at 1.5 Tesla has been documented in peer-reviewed literature as of ACR guidance publications. The ACR recommends avoiding gadolinium-based contrast agents during pregnancy unless the benefit clearly outweighs risk, because gadolinium crosses the placenta and animal studies have shown dose-dependent fetal harm at high exposures.

Ultrasound uses sound waves with no ionizing component and no confirmed harm at diagnostic power levels. It is the default modality for fetal surveillance, pelvic pathology evaluation, and obstetric monitoring throughout all trimesters. The ultrasound modality page covers technical operating parameters in detail.

Common Scenarios

The following scenarios illustrate how modality selection shifts based on clinical urgency and gestational age:

  1. Suspected pulmonary embolism (PE) — CT pulmonary angiography (CTPA) and ventilation-perfusion (V/Q) scintigraphy are both acceptable; CTPA delivers higher breast radiation dose to the mother but lower fetal dose than V/Q in some protocols. ACOG and ACR guidance supports CTPA as first-line when PE is strongly suspected.

  2. Appendicitis evaluation — Ultrasound is first-line; MRI without contrast is second-line when ultrasound is non-diagnostic; CT is reserved for cases where MRI is unavailable and clinical urgency is high.

  3. Kidney stones / urolithiasis — Ultrasound first, then low-dose CT if required for surgical planning.

  4. Neurological emergency (stroke, intracranial hemorrhage) — CT head is appropriate; fetal dose from a head CT is negligible (approximately <0.001 mGy) due to distance from the uterus.

  5. Trauma — Full trauma CT protocols are not withheld when maternal life is at risk, because untreated maternal shock carries direct fetal mortality risk. The emergency imaging page covers triage imaging frameworks.

Decision Boundaries

Decision-making for imaging in pregnancy follows a structured hierarchy:

  1. Confirm clinical necessity — Determine whether imaging will change management. If not, defer.
  2. Choose the lowest-radiation modality that answers the clinical question. Ultrasound → MRI → CT is the standard escalation path for most pelvic and abdominal indications.
  3. Assess gestational age — Organogenesis (weeks 2–8) represents peak vulnerability for teratogenic effects; fetal neural development continues through the third trimester, but high-dose CNS effects require doses above 100 mGy, which no standard diagnostic protocol approaches.
  4. Evaluate contrast agent need — Iodinated IV contrast is classified by the ACR as a Category B analog (no confirmed human fetal harm, animal studies reassuring) but is withheld unless required. Gadolinium is withheld unless essential.
  5. Document the risk-benefit discussion — Institutional protocols at Joint Commission–accredited facilities require documentation of indication and fetal dose estimate for pregnant patients receiving CT or fluoroscopy.

A contrast-free MRI and a gadolinium-enhanced MRI differ not only in fetal exposure but in diagnostic yield for conditions such as placenta accreta spectrum, where enhancement patterns are diagnostically important. The choice is made jointly by the ordering clinician and the interpreting radiologist. An overview of imaging modalities and how clinicians select among them is available on the radiology authority home.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)